Helen Torley: CEO of Halozyme Therapeutics

Release Date:

Helen Torley, CEO of Halozyme Therapeutics, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how Halozyme is working to reinvent the patient experience by easing the burden of treatment and improving patient outcomes.

Helen Torley: CEO of Halozyme Therapeutics

Title
BioBoss
Copyright
Release Date

flashback